SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Nectar Lifesciences informs about resignation of CS cum CO

28 Feb 2025 Evaluate

Pursuant to Regulation 30 of the Securities and Exchange of Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘LODR Regulations’), Nectar Lifesciences has informed that Neha Vaishnav (ACS 67387) has tendered her resignation vide letter dated February 28, 2025, from the post of Company Secretary (CS) & Compliance Officer (CO) of the Company due to personal reasons with effect from close of business hours on February 28, 2025. The required details pursuant to the LODR Regulations are annexed as Annexure-A.

The above information is a part of company’s filings submitted to BSE.

Nectar Lifesciences Share Price

12.99 0.58 (4.67%)
17-Apr-2026 10:16 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1695.00
Dr. Reddys Lab 1223.95
Cipla 1240.50
Zydus Lifesciences 944.65
Lupin 2333.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×